The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years

BACKGROUND: Coronary heart disease (CHD) risk increases with age; yet lipid-lowering therapies are significantly under-utilized in patients > 65 years. The objective was to evaluate the safety and efficacy of lipid-lowering therapies in older patients treated with atorvastatin 10 mg + ezetimibe 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Yehuda, Ori, Wenger, Nanette K., Constance, Christian, Zieve, Franklin, Hanson, Mary E., Lin, Jian-Xin, Shah, Arvind K., Jones-Burton, Charlotte, Tershakovec, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2011
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390058/
https://www.ncbi.nlm.nih.gov/pubmed/22783278
http://dx.doi.org/10.3724/SP.J.1263.2011.00001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390058/
https://www.ncbi.nlm.nih.gov/pubmed/22783278
http://dx.doi.org/10.3724/SP.J.1263.2011.00001

Ejemplares similares